Online tool for psychosis support tested in clinics – but study stopped early

NCT ID NCT06002958

Terminated Knowledge-focused Sponsor: University of North Carolina, Chapel Hill Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study looked at whether a digital platform called Horyzons could be used in clinics that help young people with early psychosis. The platform offers therapy content and a safe social network. Researchers wanted to understand what helps or hinders its use in real-world care. The study was terminated, so findings are limited.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Horyzons digital platform (therapeutic content and moderated social network)
What this could lead to: If successful, this could show how to bring online support tools into routine care for early psychosis.
What could go wrong: The trial was terminated, so results are limited. It was a small implementation study, not designed to prove clinical benefit.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SCHIZOAFFECTIVE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

psychotic disorder Psychotic Disorders schizoaffective disorder schizophrenia schizophreniform disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SCHIZOAFFECTIVE DISORDER SCHIZOPHRENIA SCHIZOPHRENIFORM DISORDERS UNSPECIFIED OR OTHER PSYCHOTIC DISORDERS

Contacts and locations

Locations

University of North Carolina at Chapel Hill

Chapel Hill, North Carolina, 27599, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.